2022 BRACE Award Venture Competition

The BRACE Award Venture Competition Selection Committee is comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the Asian Fund for Cancer Research (AFCR). Its members will determine the winning business among the event’s semi-finalists. The winner will receive the equivalent of up to US$600,000 in equity investment funding from AFCR, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for early-stage oncology start-ups that are creating life-saving innovations!

Webster Cavenee, Ph.D. | Co-chair
Director of Strategic Alliances, Ludwig Institute for Cancer Research, Distinguished Professor of Medicine, University of California San Diego

Raju Kucherlapati, Ph.D. | Co-chair
Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Pamela Garzone, Ph.D.
Former Chief Medical Officer, Calibr at Scripps Research

Brian Leyland-Jones, MBBS, Ph.D.
Chief Medical Officer, AIM-HI Accelerator Fund

Scott Lippman, M.D.
Director, Moores Cancer Center, UC San Diego Health

Fei Shen, Ph.D.
Managing Director, Boehringer Ingelheim Venture Fund USA

Alfred Slanetz, Ph.D.
President & CEO, Geneius Biotechnology, Inc.

Supporters & Sponsors

Kanaga Sabapathy, Ph.D.
Head, Division of Cellular and Molecular Research, National Cancer Center Singapore

Dimitra Georganopoulou, Ph.D.
Innovation Faculty, MIT linQ CATALYST

Wai-Kwan Alfred Yung, M.D.
Professor, Department of Neuro-Oncology, University of Texas, MD Anderson Cancer Center

Aleksandra Filipovic, M.D., Ph.D.
Head of Oncology, PureTech Health